ARTICLE | Company News
Telix, Atlab deal
February 10, 2017 8:13 PM UTC
Telix and single-asset company Atlab partnered to develop radiolabeled variants of Atlab's huJ591 to treat metastatic prostate cancer. Telix also gained an exclusive option to acquire Atlab and has on...
BCIQ Company Profiles